Freedom EVO® gives RIA workflows a boost

 

 

Shin Jin Medics, Inc. in Koyang-Si, South Korea, a manufacturer of in vitro immunodiagnostic products, has chosen Tecan’s Freedom EVO® platform as a critical component in its automated radioimmunoassay (RIA) workflow solution, the RIA Automated Laboratory System (RALSystem).

 

Mr Seung-Jae Lee, manager of diagnostic instrument engineering at Shin Jin Medics, explained: “We developed the RALSystem, consisting of Tecan’s Freedom EVO 150 liquid handling workstation integrated with our gamma counter, washer and shaker, to perform automated RIAs. We chose the Freedom EVO for the sample handling of the workflow because of its flexibility and compatibility with our own systems; our proprietary tube rack carries the total workflow through all four devices, minimizing human error and saving labor and time. The Freedom EVO takes 10 minutes to distribute 100 samples into 500 reaction tubes, and the whole process from sample distribution to results takes about one or two hours, compared to several more hours it would take to do these assays manually.”

 

“We received comprehensive training from Tecan for running and maintaining the instruments, as well as application and software support. We have been using the Freedom EVO routinely in the RALSystem since the beginning of 2008, and everything has worked smoothly, without a problem,” concluded Mr Lee.

To find out more on Tecan’s Freedom EVO workstations, visit www.tecan.com/freedomevo

 

 

 

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).

 

 

Media contacts: